These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34185)

  • 1. Antipsychotic effect of propranolol on chronic schizophrenics: study of a gradual treatment regimen.
    Elizur A; Segal Z; Yeret A; Davidson S; Atsmon A
    Psychopharmacology (Berl); 1979 Jan; 60(2):189-94. PubMed ID: 34185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients.
    Lindström LH; Persson E
    Br J Psychiatry; 1980 Aug; 137():126-30. PubMed ID: 6107136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
    Pugh CR; Steinert J; Priest RG
    Br J Psychiatry; 1983 Aug; 143():151-5. PubMed ID: 6137255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextro-propranolol and depressive symptoms in a schizophrenic population.
    Manchanda R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(5):625-32. PubMed ID: 3321153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of propranolol and thioridazine on positive and negative symptoms of schizophrenia.
    Eccleston D; Fairbairn AF; Hassanyeh F; McClelland HA; Stephens DA
    Br J Psychiatry; 1985 Dec; 147():623-30. PubMed ID: 3913486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in schizophrenia.
    Sethi BB; Dubé S
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):89-99. PubMed ID: 6682990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response study of propranolol in chronic schizophrenics.
    Gardos G; Cole JO; Volicer L; Orzack MH; Oliff AC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):314-23. PubMed ID: 4145858
    [No Abstract]   [Full Text] [Related]  

  • 8. Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia.
    Manchanda R; Hirsch SR
    Br J Psychiatry; 1986 Jun; 148():701-7. PubMed ID: 2877702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.
    Zohar J; Bannet J; Drummer D; Fisch R; Epstein RP; Belmaker RH
    Biol Psychiatry; 1983 May; 18(5):553-60. PubMed ID: 6305430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some clinical and metabolic aspects of propranolol in chronic schizophrenia.
    King DJ; Turkson SN; Liddle J; Kinney CD
    Br J Psychiatry; 1980 Nov; 137():458-68. PubMed ID: 7008891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol in the control of schizophrenic symptoms.
    Yorkston NJ; Zaki SA; Malik MK; Morrison RC; Havard CW
    Br Med J; 1974 Dec; 4(5945):633-5. PubMed ID: 4441828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of propranolol in chronic schizophrenia.
    Myers DH; Campbell PL; Cocks NM; Flowerdew JA; Muir A
    Br J Psychiatry; 1981 Aug; 139():118-21. PubMed ID: 7030444
    [No Abstract]   [Full Text] [Related]  

  • 16. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics.
    Hicks PB; Vinogradov S; Riney SJ; Su K; Csernansky JG
    J Clin Psychopharmacol; 1989 Jun; 9(3):209-12. PubMed ID: 2567742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.
    McClelland HA; Farquharson RG; Leyburn P; Furness JA; Schiff AA
    Arch Gen Psychiatry; 1976 Dec; 33(12):1435-9. PubMed ID: 11760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DL-propranolol and chlorpromazine following admission for schizophrenia. A controlled comparison.
    Yorkston NJ; Zaki SA; Weller MP; Gruzelier JH; Hirsch SR
    Acta Psychiatr Scand; 1981 Jan; 63(1):13-27. PubMed ID: 7015789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open clinical trial of fenfluramine in chronic schizophrenia: a pilot study.
    Kolakowska T; Gadhvi H; Molyneux S
    Int Clin Psychopharmacol; 1987 Jan; 2(1):83-8. PubMed ID: 2889761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.